Market Research Logo

Global Ophthalmology Therapeutics Market 2019-2023

Global Ophthalmology Therapeutics Market 2019-2023

About this market

The new drug approvals and strong drug pipeline will trigger the ophthalmology therapeutics market growth in the forthcoming years. Top players in the market are focusing on the development of disease-modifying drugs for treating the rising incidences of eye diseases. Furthermore, several market players are focusing on achieving new drug approvals and gene therapy approvals for treating the eye diseases, thus, contributing significantly to the market growth. Technavio’s analysts have predicted that the ophthalmology therapeutics market will register a CAGR of nearly 6% by 2023.

Market Overview

New drug approvals and strong drug pipeline

One of the growth drivers of the global ophthalmology therapeutics market is new drug approvals and strong drug pipeline. The increasing incidence of eye disease is encouraging the top players to focus on the development of disease-modifying drugs to treat these diseases, which will drive the growth of the market during the forecast period.

High cost of treatment

One of the challenges in the growth of the global ophthalmology therapeutics market is the high cost of treatment. The high cost involved in treating various eye diseases can hamper the growth of the market.

For the detailed list of factors that will drive and challenge the growth of the ophthalmology therapeutics market during 019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several market players. Companies are focusing on developing innovative treatments for glaucoma and other eye conditions. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.


Press Release

Technavio Announces the Publication of its Research Report – Global Ophthalmology Therapeutics Market 2019-2023

Technavio recognizes the following companies as the key players in the global ophthalmology therapeutics market: ALLERGAN, F. Hoffmann-La Roche Ltd, Novartis AG, Regeneron Pharmaceuticals Inc, and Santen Pharmaceutical Co., Ltd.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the development of novel drug delivery systems.”

According to the report, one of the major drivers for this market is the new drug approvals and strong drug pipeline.

Further, the report states that one of the major factors hindering the growth of this market is the limitations and side-effects associated with current ophthalmology therapeutics.

Companies Mentioned

ALLERGAN,
F. Hoffmann-La Roche Ltd
Novartis AG
Regeneron Pharmaceuticals Inc
Santen Pharmaceutical Co., Ltd.

  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Retinal disorder therapeutics - Market size and forecast 2018-2023
      • Table Retinal disorder therapeutics - Market size and forecast 2018-2023 ($ millions)
      • Table Retinal disorder therapeutics - Year-over-year growth 2019-2023 (%)
    • Glaucoma therapeutics - Market size and forecast 2018-2023
      • Table Glaucoma therapeutics - Market size and forecast 2018-2023 ($ millions)
      • Table Glaucoma therapeutics - Year-over-year growth 2019-2023 (%)
    • Dry eye syndrome therapeutics - Market size and forecast 2018-2023
      • Table Dry eye syndrome therapeutics - Market size and forecast 2018-2023 ($ millions)
      • Table Dry eye syndrome therapeutics - Year-over-year growth 2019-2023 (%)
    • Eye infections and inflammation therapeutics - Market size and forecast 2018-2023
      • Table Eye infections and inflammation therapeutics - Market size and forecast 2018-2023 ($ millions)
      • Table Eye infections and inflammation therapeutics - Year-over-year growth 2019-2023 (%)
    • Other therapeutics - Market size and forecast 2018-2023
      • Table Other therapeutics - Market size and forecast 2018-2023 ($ millions)
      • Table Other therapeutics - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision Framework
  • Drivers and challenges
    • Market drivers
      • Table Late-stage pipeline drugs
    • Market challenges
      • Table Patent expiry
      • Table Impact of drivers and challenges
  • Market trends
    • Table Mergers and acquisitions in 2017 and 2018
    • Table Gene therapies under development
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • ALLERGAN
      • Table ALLERGAN - Vendor overview
      • Table ALLERGAN - Business segments
      • Table ALLERGAN - Organizational developments
      • Table ALLERGAN - Geographic focus
      • Table ALLERGAN - Segment focus
      • Table ALLERGAN - Key offerings
    • F. Hoffmann-La Roche Ltd
      • Table F. Hoffmann-La Roche Ltd - Vendor overview
      • Table F. Hoffmann-La Roche Ltd - Business segments
      • Table F. Hoffmann-La Roche Ltd - Organizational developments
      • Table F. Hoffmann-La Roche Ltd - Geographic focus
      • Table F. Hoffmann-La Roche Ltd - Segment focus
      • Table F. Hoffmann-La Roche Ltd - Key offerings
    • Novartis AG
      • Table Novartis AG - Vendor overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Organizational developments
      • Table Novartis AG - Geographic focus
      • Table Novartis AG - Segment focus
      • Table Novartis AG - Key offerings
    • Regeneron Pharmaceuticals, Inc.
      • Table Regeneron Pharmaceuticals, Inc. - Vendor overview
      • Table Regeneron Pharmaceuticals, Inc. - Business segments
      • Table Regeneron Pharmaceuticals, Inc. - Organizational developments
      • Table Regeneron Pharmaceuticals, Inc. - Key offerings
    • Santen Pharmaceutical Co., Ltd.
      • Table Santen Pharmaceutical Co., Ltd. - Vendor overview
      • Table Santen Pharmaceutical Co., Ltd. - Business segments
      • Table Santen Pharmaceutical Co., Ltd. - Organizational developments
      • Table Santen Pharmaceutical Co., Ltd. - Geographic focus
      • Table Santen Pharmaceutical Co., Ltd. - Key offerings
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report